|
|
Volumn 370, Issue 9597, 2007, Pages 1479-
|
|
New treatments for age-related macular degeneration
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
PEGAPTANIB;
RANIBIZUMAB;
VASCULOTROPIN;
ANGIOGENESIS INHIBITOR;
APTAMER;
MONOCLONAL ANTIBODY;
CONCENTRATION RESPONSE;
DRUG BLOOD LEVEL;
DRUG PACKAGING;
HUMAN;
LETTER;
NONHUMAN;
OFF LABEL DRUG USE;
PRIORITY JOURNAL;
RABBIT;
RETINA MACULA AGE RELATED DEGENERATION;
RISK BENEFIT ANALYSIS;
ANIMAL;
BLOOD;
NOTE;
REFERENCE VALUE;
RETINA MACULA DEGENERATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
APTAMERS, NUCLEOTIDE;
HUMANS;
MACULAR DEGENERATION;
RABBITS;
REFERENCE VALUES;
|
|
EID: 35448974867
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(07)61624-9 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
